Rotavirus vaccination effectiveness: A case-case study in the EDICS project, Castellón (Spain)

Vaccine

Volumn 30, Issue 52, 2012, Pages 7536-7540

  Bellido Blasco, Juan B ^a,c,d,e   Sabater Vidal, Susana ^b   Salvador Ribera, M del Mar ^a,c   Arnedo Pena, Alberto ^a,c   Tirado Balaguer, M Dolores ^b   Meseguer Ferrer, Noemí ^a   Silvestre Silvestre, Esther ^a   Romeu García, M àngels ^a   Herrero Carot, Concha ^a   Moreno Muñoz, M Rosario ^b  

^a Center Public Health Castellon   (Spain)

^b HOSPITAL GENERAL DE CASTELLÓN   (Spain)

^c CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^d CEU Cardinal Herrera University   (Spain)

^e Center for Public Health Research CSISP   (Spain)

Author keywords

Case control studies; Effectiveness; Rotavirus; Spain; Vaccine

Indexed keywords

ROTAVIRUS VACCINE;

ADENOVIRUS; AEROMONADACEAE; ARTICLE; CAMPYLOBACTER; DIARRHEA; FEMALE; GASTROENTERITIS; HUMAN; IMMUNIZATION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; ROTAVIRUS; ROTAVIRUS INFECTION; SALMONELLA; SPAIN; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

CASE-CONTROL STUDIES; CHILD, PRESCHOOL; DIARRHEA; FEMALE; GASTROENTERITIS; HUMANS; INFANT; MALE; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; SPAIN; VACCINATION;

EID: 84870495337     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.10.049     Document Type: Article

References (28)

1. Bányai K., László B., Duque J., Steele A.D., Nelson E.A., Gentsch J.R., et al. Systematic review of regional and temporal trends in global rotavirus strain diversity in the pre rotavirus vaccine era: insights for understanding the impact of rotavirus vaccination programs. Vaccine 2012, 30(Suppl. 1):A122-A130.
2. Parashar U.D., Burton A., Lanata C., Boschi-Pinto C., Shibuya K., Steele D., et al. Global mortality associated with rotavirus disease among children in 2004. J Infect Dis 2009, 1(200). 1:S9-S15.
3. Alemany-Vilches L., Moraga-Llop F., García-Jiménez S. Epidemiología de las infecciones por rotavirus. Hospitalizaciones, casos comunitarios e infección nosocomial. Epidemiología de las gastroenteritis agudas víricas 2007, 79-98. EMISA-Sociedad Española de Epidemiología, España. J. Bellido-Blasco, A.M. García (Eds.).
4. Wilhelmi I., Roman E., Sánchez-Fauquier A. Viruses causing gastroenteritis. Clin Microbiol Infect 2003, 9:247-262.
5. CDC Rotavirus surveillance - worldwide, 2001-2008. MMWR 2008, 57:1255-1257.
6. Bellido J.B., Galiano J.V., Tirado M.D., González-Cano J.M., Safont L. Incidence of sporadic cases of the most frequent intestinal infections in Castellon. Rev Esp Salud Publica 2003, 77:629-638.
7. Bellido-Blasco J.B., Celades-Porcar M.E., Tirado-Balaguer M.D., González-Cano J.M., Gil-Ortuño M., Arnedo-Pena A. Infectious diarrhea study in Castellón. Spain (EDICS): population incidence of sporadic cases in 2004 and comparison with the year 2000. Med Clin 2006, 127:448-450.
8. Diez-Domingo J., Martín I.O., Sanz A.B., López A.G., Martínez C.C., Boronat C.P., et al. Rotavirus gastroenteritis among children under five years of age in Valencia, Spain. Pediatr Infect Dis J 2006, 25:455-457.
9. Sánchez-Fauquier A., Montero V., Moreno S., Solé M., Colomina J., Iturriza-Gomara M., et al. Human rotavirus G9 and G3 as major cause of diarrhea in hospitalized children, Spain. Emerg Infect Dis 2006, 12:1536-1541.
10. Sánchez-Fauquier A., Montero V., Colomina J., González-Galán V., Aznar J., Aisa M.L., et al. Global study of viral diarrhea in hospitalized children in Spain: results of structural surveillance of viral gastroenteritis net work (VIGESS-net) 2006-2008. J Clin Virol 2011, 52:353-358.
11. Ruiz-Palacios G.M., Pérez-Schael I., Velázquez F.R., Abate H., Breuer T., Clemens S.C., et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006, 354(January):11-22.
12. Vesikari T., Matson D.O., Dennehy P., Van Damme P., Santosham M., Rodriguez Z., et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006, 354:23-33.
13. Fischer Walker C.L., Black R.E. Rotavirus vaccine and diarrhea mortality: quantifying regional variation in effect size. BMC Public Health 2011, 11:S16.
14. Patel M.M., Parashar U.D. Assessing the effectiveness and public health impact of rotavirus vaccines after introduction in immunization programs. J Infect Dis 2009, 1(200):S291-S299.
15. Tate J.E., Parashar U.D. Monitoring impact and effectiveness of rotavirus vaccination. Expert Rev Vaccines 2011, 10:1123-1125.
16. Bellido-Blasco J.B., González-Cano J.M., Galiano-Arlandis J.V., Herrero-Carot C., Tirado-Balaguer M.D., Arnedo-Pena A., et al. Group EDICS. Risk factors for the occurrence of sporadic Campylobacter, Salmonella and rotavirus diarrhea in preschool children. Ann Pediatr 2007, 66:367-374.
17. McCarthy N., Gieseke J. Case-case comparisons to study causation of common infectious disease. Int J Epidemiol 1999, 28:764-768.
18. Sato T. Confidence limits for the common odds ratio based on the asymptotic distribution of the Maentel-Haenszel estimator. Biometrics 1990, 46:71-80.
19. Vesikari T., Karvonen A., Prymula R., Schuster V., Tejedor J.C., Cohen R., et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet 2007, 370:1757-1763.
20. ®, in Finnish infants up to 3 years of age: the Finnish extension study. Eur J Pediatr 2010, 169:1379-1386.
21. Castilla J., Beristain X., Martínez-Artola V., Navascués A., García Cenoz M., Alvarez N., et al. Effectiveness of rotavirus vaccines in preventing cases and hospitalizations due to rotavirus gastroenteritis in Navarre, Spain. Vaccine 2012, 30:539-543.
22. Sahni L.C., Boom J.A., Patel M.M., Baker C.J., Rench M.A., Parashar U.D., et al. Use of an immunization information system to assess the effectiveness of pentavalent rotavirus vaccine in US children. Vaccine 2010, 28:6314-6317.
23. Puig-Barberà J., Arnedo-Pena A., Pardo-Serrano F., Tirado-Balaguer M.D., Pérez-Vilar S., Silvestre-Silvestre E., et al. Effectiveness of seasonal 2008-2009, 2009-2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellón, Spain. A test-negative, hospital-based, case-control study. Vaccine 2010, 28:7460-7467.
24. Desai S.N., Esposito D.B., Shapiro E.D., Dennehy P.H., Vázquez M. Effectiveness of rotavirus vaccine in preventing hospitalization due to rotavirus gastroenteritis in young children in Connecticut, USA. Vaccine 2010, 28:7501-7506.
25. Martinón-Torres F., Bouzón Alejandro M., Redondo Collazo L., Sánchez Lastres J.M., Pértega Díaz S., Seoane Pillado M.T., et al. ROTACOST research team effectiveness of rotavirus vaccination in Spain. Hum Vaccin 2011, 7:757-761.
26. Muhsen K., Chodick G., Goren S., Shalev V., Cohen D. The uptake of rotavirus vaccine and its effectiveness in preventing acute gastroenteritis in the community. Vaccine 2010, 29:91-94.
27. ® (RV5), between doses of a 3-dose series and with less than 3 doses (incomplete regimen). Hum Vaccin 2011, 7:563-568.
28. Gutierrez-Gimeno M.V., Martin-Moreno J.M., Díez-Domingo J., Asensi-Botet F., Hernández-Marco R., Correcher-Medina P., et al. Nosocomial rotavirus gastroenteritis in Spain: a multicenter prospective study. Pediatr Infect Dis J 2010, 29:23-27.